Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Neoplasms 2Breast Neoplasms 2Rectal Neoplasms 1Motor Activity 1Lung Neoplasms 1Hodgkin Disease 1Digestive System Neoplasms 1Cognitive Dysfunction 1Cardiovascular Diseases 1Brain Neoplasms 1

Interventions

Trastuzumab 597Paclitaxel 562Cyclophosphamide 545Docetaxel 479Capecitabine 388Letrozole 350Fulvestrant 311Doxorubicin 285Carboplatin 277Tamoxifen 257Anastrozole 219exemestane 211Epirubicin 210Radiotherapy 197Bevacizumab 189pertuzumab 177Gemcitabine 163Vinorelbine 162pembrolizumab 161Lapatinib 161palbociclib 152Exercise 132Fluorouracil 118Albumin-Bound Paclitaxel 116eribulin 108Magnetic Resonance Spectroscopy 108130-nm albumin-bound paclitaxel 107Everolimus 103Taxes 96Cisplatin 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Breast Neoplasms × Physical Conditioning, Human × Clear all
NCT05184582 2025-09-22

Neo-ACT

Karolinska Institutet

Phase NA Recruiting
712 enrolled
Breast

Breast Neoplasms

NCT04586517 2022-11-02

Effect of Heavy-load Resistance Training During Chemotherapy on Muscle Cellular Outcomes

Uppsala University

Phase NA Unknown
40 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡